AMGN vs FDBC · P/E 24, rev $10.05B vs P/E 9.3, rev $62.2M
Amgen Inc (AMGN) versus Fidelity D&D Bancorp Inc (FDBC) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Fidelity D&D Bancorp Inc (FDBC) is a banks - regional company listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported FDBC revenue for 2026-06-30 was $62.2M. Net income was $15.3M. FDBC currently screens at market cap $276.8M and trailing P/E 9.3.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. FDBC currently screens at market cap $276.8M and trailing P/E 9.3.
Not investment advice. Open the AMGN and FDBC stock pages for the full models.
Not investment advice.